Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other Non-Current Assets (2016 - 2025)

Mimedx (MDXG) has disclosed Other Non-Current Assets for 14 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 8.37% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, up 8.37% year-over-year, with the annual reading at $7.3 million for FY2025, 8.37% up from the prior year.
  • Other Non-Current Assets hit $7.3 million in Q4 2025 for Mimedx, up from $3.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $7.3 million in Q4 2025 to a low of $146000.0 in Q2 2023.
  • Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $328500.0 in 2021.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 85.95% in 2021 and later surged 3174.15% in 2024.
  • Year by year, Other Non-Current Assets stood at $186000.0 in 2021, then surged by 615.59% to $1.3 million in 2022, then plummeted by 84.6% to $205000.0 in 2023, then soared by 3174.15% to $6.7 million in 2024, then increased by 8.37% to $7.3 million in 2025.
  • Business Quant data shows Other Non-Current Assets for MDXG at $7.3 million in Q4 2025, $3.0 million in Q3 2025, and $990000.0 in Q2 2025.